We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
-3.36%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$515M
AUM Growth
-$30.1M
Cap. Flow
-$7.12M
Cap. Flow %
-1.38%
Top 10 Hldgs %
16.03%
Holding
304
New
12
Increased
100
Reduced
100
Closed
22

Top Buys

1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$1.65M
2
ETN icon
Eaton
ETN
+$645K
3
OII icon
Oceaneering
OII
+$550K
4
CTSH icon
Cognizant
CTSH
+$485K
5
BPL
Buckeye Partners, L.P.
BPL
+$414K

Top Sells

1
TCOM icon
Trip.com Group
TCOM
+$1.19M
2
AME icon
Ametek
AME
+$1.17M
3
AMX icon
America Movil
AMX
+$674K
4
JPM icon
JPMorgan Chase
JPM
+$542K
5
C icon
Citigroup
C
+$501K

Sector Composition

1 Technology 21.45%
2 Industrials 17.09%
3 Financials 8.7%
4 Healthcare 8.6%
5 Energy 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
1
IPG Photonics
IPGP
$4.43B
$12M 2.33%
174,098
-2,016
-1% -$136K
AZZ icon
2
AZZ Inc
AZZ
$4.42B
$8.37M 1.63%
200,414
-576
-0.3% -$26.3K
AKAM icon
3
Akamai
AKAM
$17.5B
$8.33M 1.62%
139,262
-379
-0.3% -$22.8K
FFIV icon
4
F5
FFIV
$23.1B
$8.07M 1.57%
67,938
-994
-1% -$117K
ICE icon
5
Intercontinental Exchange
ICE
$79B
$8.05M 1.57%
206,475
-1,265
-0.6% -$48.5K
IHS
6
DELISTED
IHS INC CL-A COM STK
IHS
$7.95M 1.54%
63,487
-203
-0.3% -$27.5K
TCOM icon
7
Trip.com Group
TCOM
$26.7B
$7.73M 1.5%
272,294
-37,468
-12% -$1.19M
UTHR icon
8
United Therapeutics
UTHR
$22.7B
$7.67M 1.49%
59,582
-1,573
-3% -$162K
SWI
9
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
$7.23M 1.4%
171,903
+364
+0.2% +$15.1K
MSCI icon
10
MSCI
MSCI
$45.8B
$7.14M 1.39%
151,798
-824
-0.5% -$38.1K
GHM icon
11
Graham Corp
GHM
$1.26B
$7.05M 1.37%
245,166
-1,268
-0.5% -$39.5K
HUBG icon
12
HUB Group
HUBG
$3.13B
$6.94M 1.35%
342,350
+18
+0% +$410
CYBX
13
DELISTED
CYBERONICS INC
CYBX
$6.89M 1.34%
134,670
-1,536
-1% -$88.5K
RHT
14
DELISTED
Red Hat Inc
RHT
$6.79M 1.32%
120,837
-48
-0% -$2.8K
MSM icon
15
MSC Industrial Direct
MSM
$6.97B
$6.75M 1.31%
79,043
-497
-0.6% -$44.3K
HXL icon
16
Hexcel
HXL
$7.83B
$6.7M 1.3%
168,823
-436
-0.3% -$17.2K
GGG icon
17
Graco
GGG
$12.4B
$6.7M 1.3%
275,253
-1,776
-0.6% -$45K
ARUN
18
DELISTED
ARUBA NETWORKS, INC.
ARUN
$6.66M 1.29%
308,637
-953
-0.3% -$18.7K
MO icon
19
Altria Group
MO
$124B
$6.62M 1.29%
144,067
-1,203
-0.8% -$51.5K
FTNT icon
20
Fortinet
FTNT
$118B
$6.53M 1.27%
1,291,385
+5,165
+0.4% +$26.1K
NOG icon
21
Northern Oil and Gas
NOG
$2.31B
$6.3M 1.22%
44,282
-172
-0.4% -$27.6K
HDB icon
22
HDFC Bank
HDB
$135B
$6.17M 1.2%
529,636
+1,072
+0.2% +$13K
ALGT icon
23
Allegiant Air
ALGT
$2.71B
$6.05M 1.18%
48,930
-1,881
-4% -$230K
NATI
24
DELISTED
National Instruments Corp
NATI
$5.88M 1.14%
190,238
-2,114
-1% -$68.4K
FCX icon
25
Freeport-McMoran
FCX
$83.9B
$5.68M 1.1%
173,891
-3,241
-2% -$118K
1
2 3 4 5

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return

Stanley-Laman Group's Q3 2014 Portfolio in Review

As of Q3 2014, Stanley-Laman Group held 304 positions worth $515M, down 5.5% from $545M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q3 2014 filing shows 12 new, 100 increased, 100 reduced and 22 closed positions. Its largest new stake was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M. The largest sale was Trip.com Group, an estimated $1.19M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Stanley-Laman Group's largest Q3 2014 buy was Eagle Pharmaceuticals, Inc.: 132,790 shares worth $1.68M.
  • Stanley-Laman Group added most to Eaton in Q3 2014, an estimated $645K increase.
  • Stanley-Laman Group's biggest Q3 2014 reduction was Trip.com Group, cutting an estimated $1.19M.
  • Stanley-Laman Group fully exited Ametek in Q3 2014, selling an estimated $1.17M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $515M portfolio in Q3 2014.
  • Stanley-Laman Group opened 12 new positions and closed 22 in Q3 2014.
  • Stanley-Laman Group's portfolio value fell 5.5% quarter-over-quarter to $515M.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.